Case Report: When dual immune checkpoint blockade strikes back: cadonilimab-induced hypersensitivity in solid tumors — a case series and review
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but immune-related hypersensitivity reactions remain a clinical concern. Cadonilimab, a novel PD-1/CTLA-4 bispecific antibody, has demonstrated encouraging antitumor efficacy across various solid tumors; however, hyper...
Saved in:
| Main Authors: | Ping Song, Yuqi Jin, Linglin Fu, Fengming Yang, Yinuo Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1643279/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review
by: Ping Song, et al.
Published: (2025-03-01) -
Whitening toothpaste-induced oral mucosal hypersensitivity reaction resembling oral lichenoid reaction: a clinically diagnosed case report
by: Fumin Zheng, et al.
Published: (2025-07-01) -
Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study
by: Jian Chen, et al.
Published: (2025-07-01) -
Clinical progress of cadonilimab in the treatment of malignant tumor
by: ZHANG Xiaoqing, et al.
Published: (2025-06-01) -
Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy
by: Jianquan Yang, et al.
Published: (2025-07-01)